Goldman Sachs
MESO

Goldman Sachs’s Mesoblast MESO Stock Holding History

Goldman Sachs’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.35M Sell
395,612
-1,603
-0.4% -$23.8K ﹤0.01% 3825
2026
Q1 		$6.11M Buy
397,215
+1,365
+0.3% +$22.7K ﹤0.01% 3499
2025
Q4 		$7.14M Sell
395,850
-11,430
-3% -$197K ﹤0.01% 3417
2025
Q3 		$6.56M Sell
407,280
-8,185
-2% -$120K ﹤0.01% 3399
2025
Q2 		$4.52M Buy
415,465
+158,322
+62% +$1.77M ﹤0.01% 3525
2025
Q1 		$3.21M Buy
+257,143
New +$4.24M ﹤0.01% 3774
2023
Q1 		– Sell
-18,204
Closed -$106K – 6115
2022
Q4 		$106K Buy
+18,204
New +$114K ﹤0.01% 5471
2022
Q1 		– Sell
-27,521
Closed -$264K – 6773
2021
Q4 		$264K Sell
27,521
-142
-0.5% -$1.65K ﹤0.01% 5740
2021
Q3 		$333K Sell
27,663
-1,286
-4% -$17.9K ﹤0.01% 5433
2021
Q2 		$433K Buy
28,949
+812
+3% +$12.7K ﹤0.01% 5303
2021
Q1 		$465K Buy
28,137
+15,597
+124% +$295K ﹤0.01% 5173
2020
Q4 		$213K Sell
12,540
-4,798
-28% -$118K ﹤0.01% 5059
2020
Q3 		$644K Sell
17,338
-84,695
-83% -$2.65M ﹤0.01% 4343
2020
Q2 		$2.32M Buy
+102,033
New +$2.18M ﹤0.01% 3352
2018
Q1 		– Sell
-71,500
Closed -$835K – 6198
2017
Q4 		$835K Hold
71,500
– – ﹤0.01% 4454
2017
Q3 		$784K Sell
71,500
-50,239
-41% -$674K ﹤0.01% 4782
2017
Q2 		$1.94M Buy
121,739
+239
+0.2% +$4.48K ﹤0.01% 3865
2017
Q1 		$2.18M Hold
121,500
– – ﹤0.01% 3664
2016
Q4 		$1.3M Hold
121,500
– – ﹤0.01% 4229
2016
Q3 		$1.05M Hold
121,500
– – ﹤0.01% 4356
2016
Q2 		$962K Buy
+121,500
New +$1.74M ﹤0.01% 4213

Other funds holding MESO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Goldman Sachs's MESO Position: Q2 2026 in Review

Goldman Sachs reduced its Mesoblast (MESO) stake by 0.4% in Q2 2026, selling an estimated $23.8K and leaving 395,612 shares worth $5.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3825.

Goldman Sachs first reported a position in MESO in Q2 2016 and has held it in 21 quarters since. The position peaked at $7.14M in Q4 2025. 71 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Goldman Sachs held 395,612 shares of Mesoblast worth $5.35M as of Q2 2026.
  • Goldman Sachs sold 1,603 Mesoblast shares in Q2 2026, an estimated $23.8K.
  • Mesoblast made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3825 holding.
  • Goldman Sachs first reported a position in Mesoblast in Q2 2016 and has held it in 21 quarters since.
  • Goldman Sachs's Mesoblast position peaked at $7.14M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.